Policy Statement Sign-on letter from over 100 rare disease patient organizations in support of the RARE Act of 2018
Policy Statement NORD letter in support of Connecticut House Bill 5297, an act requiring continuing medical education in screening for rare gastrointestinal cancers
Policy Statement Coalition letter asking Congress to voice opposition to the proposed rule regarding short-term, limited-duration plans (STLDs)
Policy Statement Coalition letter in opposition to Michigan Senate Bill 897, a bill requiring the state to implement a work requirement in its Medicaid program
Policy Statement Coalition letter to Secretary Azar regarding Medicare Part D’s protected classes policy
Policy Statement Coalition letter asking Governors to voice opposition to the proposed rule regarding short-term, limited-duration plans (STLDs)
Policy Statement Coalition letter asking Congress to appropriate funds for the Pediatric Device Consortia (PDC) Grant Program
Policy Statement NORD letter in support of West Virginia House Bill 4524, an act calling for prescriber communication with regard to biosimilars
Policy Statement Coalition letter in opposition of Rhode Island Senate Bill 2532, an act that would prevent copay assistance from being applied to out-of-pocket expenses
Policy Statement Sign-on letter to the Senate from 106 patient and provider organizations in opposition to the Right to Try Act
Policy Statement Updated sign-on letter from over 100 patient and provider organizations in opposition to the Right to Try Act
Policy Statement Sign-on letter from 82 patient organizations in opposition to the newest version of the Right to Try Act
Policy Statement NORD letter in support of Connecticut Senate Bill 398, an act relating to the enforcement of Connecticut’s step therapy law
Policy Statement Coalition letter to Congress regarding medical research within the fiscal year 2019 National Defense Authorization Act
Policy Statement Coalition letter to Congress in support of the Medical Nutrition Equity Act (S.1194/H.R.2587)
Policy Statement Coalition sign-on letter to Medicaid Directors on the importance of Medicaid formulary access for rare disease patients
Policy Statement NORD letter in support of Oregon House Bill 4156, an act relating to out-of-pocket costs
Policy Statement American Plasma Users (APLUS) coalition letter regarding the Patient Notification System (PNS)
Policy Statement Coalition letter to Congress regarding a desire for a hearing on ensuring patient safety and access in the midst of the Biologics Price Competition and Innovation Act (BPCIA)
Policy Statement NORD letter in support of South Dakota Senate Bill 75, an act calling for prescriber communication with regard to biosimilars